Cargando…
Repurposing calcium channel blockers as antiviral drugs
The current pandemic caused by the SARS-CoV-2 has claimed over a half a million lives within a very short span of time. A therapeutic drug which could prevent the entry and propagation of the virus is the need of the hour. Several lines of evidence collected from experimental studies older than thre...
Autores principales: | Jayaseelan, Vijayashree Priyadharsini, Paramasivam, Arumugam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438026/ https://www.ncbi.nlm.nih.gov/pubmed/32815099 http://dx.doi.org/10.1007/s12079-020-00579-y |
Ejemplares similares
-
Slow train coming: an anti-CCN2 strategy reverses a model of chronic overuse muscle fibrosis
por: Leask, Andrew
Publicado: (2020) -
COVID-19: is fibrosis the killer?
por: Leask, Andrew
Publicado: (2020) -
Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets
por: Thoutam, Akshaya, et al.
Publicado: (2020) -
The skinny on CCN2
por: Leask, Andrew
Publicado: (2008) -
Hijacking ZIP codes: posttanscriptional regulation of CCN2 by nucleophosmin
por: Leask, Andrew
Publicado: (2009)